Morsica, Giulia <br/><br/>
Comparison of IFN-alpha 2b with or without ribavirin for treatment of chronic hepatitis C in HIV-positive patients infected with hepatitis C virus genotype 3a.  [electronic resource] 

 -  AIDS (London, England)  Apr 2004 
 - 1080-2 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Controlled Clinical Trial; Letter; Comment 
<br/><br/><label>ISSN: </label>0269-9370 
<br/><br/><label>Standard No.: </label>10.1097/00002030-200404300-00022  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antiviral Agents--therapeutic use<br/>Drug Therapy, Combination<br/>Female<br/>HIV Infections--complications<br/>Hepacivirus--classification<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--therapeutic use<br/>Male<br/>Middle Aged<br/>Recombinant Proteins<br/>Ribavirin--therapeutic use